https://medicaldialogues.in/cardiology-ctvs/news/empagliflozin-proves-beneficial-in-acute-myocardial-infarction-emmy-trial-98785
AUSTRIA: Acute myocardial infarction (MI) patients who receive the SGLT2 inhibitor empagliflozin...
Create an account or login to join the discussion